Latest Anlon Healthcare stock price
Anlon Healthcare P/E Ratio
AHCL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
37.22
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
37.22
Current Price
₹142.42
EPS (TTM)
₹6.37
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
52.21
Sector Median
30.38
Sector Rank
#11 of 137
Sector Percentile
8.0%
Key P/E Ratio Insights for Anlon Healthcare
- Stock appears overvalued with PE of 37.22, suggesting caution for new investments
- Trading at discount to sector average PE of 52.21
View the AHCL equity price for detailed stock performance.
Related Pages for Anlon Healthcare
Additional stock information and data for AHCL
Sector P/E Ratio Comparison
Comparing Anlon Healthcare with other companies in Healthcare sector
Sector Average
52.21
Sector Median
30.38
Lowest P/E
1.5
Highest P/E
628.04
Companies
137
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| Amwill Health Care | AMWILL | 7.92 | ₹82 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |